Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
0.3635
Dollar change
+0.0082
Percentage change
2.29
%
Index- P/E- EPS (ttm)-2.56 Insider Own8.59% Shs Outstand10.17M Perf Week11.13%
Market Cap3.78M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float9.30M Perf Month-10.84%
Income-9.86M PEG- EPS next Q- Inst Own6.99% Short Float1.24% Perf Quarter-27.45%
Sales0.00M P/S- EPS this Y- Inst Trans40.50% Short Ratio0.21 Perf Half Y-50.88%
Book/sh0.44 P/B0.83 EPS next Y- ROA-172.77% Short Interest0.12M Perf Year-74.04%
Cash/sh0.30 P/C1.22 EPS next 5Y- ROE-308.65% 52W Range0.30 - 2.92 Perf YTD-72.04%
Dividend Est.- P/FCF- EPS past 5Y71.22% ROI-249.45% 52W High-87.55% Beta0.64
Dividend TTM- Quick Ratio4.56 Sales past 5Y-20.00% Gross Margin- 52W Low19.73% ATR (14)0.03
Dividend Ex-DateApr 23, 2008 Current Ratio4.56 EPS Y/Y TTM76.45% Oper. Margin- RSI (14)46.72 Volatility7.50% 9.38%
Employees7 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price7.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q81.63% Payout- Rel Volume0.10 Prev Close0.36
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsNov 14 AMC Avg Volume540.12K Price0.36
SMA206.33% SMA50-12.86% SMA200-45.04% Trades Volume53,784 Change2.29%
Dec-02-24 08:00AM
Nov-25-24 09:00AM
Nov-18-24 07:19AM
Nov-14-24 04:05PM
Nov-12-24 09:00AM
10:36AM Loading…
Nov-04-24 10:36AM
Oct-15-24 08:00AM
Sep-26-24 08:30AM
Sep-25-24 08:30AM
Sep-04-24 08:00AM
Aug-13-24 08:00AM
Aug-12-24 05:30PM
Jul-25-24 08:00AM
Jul-15-24 09:02AM
Jul-10-24 08:00AM
08:00AM Loading…
Jun-28-24 08:00AM
Jun-25-24 08:00AM
May-30-24 08:00AM
May-20-24 11:54AM
07:45AM
May-15-24 06:00AM
May-14-24 08:00AM
May-08-24 07:00AM
May-02-24 05:50PM
Apr-12-24 12:00PM
Apr-01-24 10:53AM
Mar-26-24 07:00AM
Mar-19-24 07:00AM
Mar-12-24 07:00AM
Feb-29-24 02:04PM
07:00AM Loading…
07:00AM
Feb-26-24 08:00AM
Feb-23-24 08:00AM
Feb-21-24 08:00AM
Jan-03-24 08:00AM
Dec-29-23 08:52AM
Dec-28-23 08:00AM
Dec-27-23 08:00AM
Dec-20-23 08:00AM
Dec-05-23 08:00AM
Nov-29-23 08:00AM
Nov-27-23 08:00AM
Nov-24-23 08:00AM
Nov-13-23 04:01PM
Oct-31-23 08:00AM
Oct-20-23 08:00AM
Oct-18-23 08:00AM
Oct-11-23 08:00AM
Oct-03-23 08:00AM
Sep-27-23 08:00AM
Sep-20-23 08:00AM
Sep-18-23 08:00AM
Sep-11-23 08:00AM
Sep-05-23 08:00AM
Aug-30-23 08:00AM
Aug-28-23 11:04AM
Aug-24-23 08:00AM
Aug-21-23 08:00AM
Aug-14-23 08:00AM
Jul-24-23 08:00AM
Jul-17-23 08:00AM
Jun-26-23 08:00AM
Jun-12-23 08:00AM
Jun-07-23 08:00AM
Jun-05-23 08:00AM
May-30-23 08:00AM
May-24-23 08:00AM
May-22-23 08:00AM
May-19-23 08:00AM
May-18-23 08:00AM
May-15-23 09:25AM
May-02-23 07:30AM
Apr-10-23 07:30AM
Apr-03-23 04:05PM
Mar-23-23 07:30AM
Mar-21-23 07:33AM
Mar-14-23 07:30AM
Feb-28-23 07:30AM
Feb-23-23 07:33AM
Feb-22-23 07:33AM
Feb-01-23 07:33AM
Dec-21-22 07:30AM
Nov-28-22 07:30AM
Nov-16-22 07:30AM
Nov-01-22 07:30AM
Oct-24-22 07:00AM
Oct-12-22 08:00AM
Aug-31-22 07:30AM
Jul-27-22 07:30AM
Jul-26-22 05:30PM
Jul-25-22 08:00AM
Jul-19-22 07:30AM
Jul-14-22 12:15PM
Jul-13-22 07:30AM
Jun-08-22 07:30AM
May-24-22 04:05PM
May-17-22 07:30AM
May-11-22 07:30AM
May-05-22 07:30AM
May-03-22 05:13PM
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company was founded on February 28, 1994 and is headquartered in Naples, FL.